Publikasi

From Neural Networks to Human Brains: The Next Tech Lea...

Neurological disorders are a silent epidemic with a vast economic footprint.  Ep...

Supreme Court Sets ‘Dangerous Precedent’ on Gender-Affi...

To be clear—regardless of the legal ruling—the science still supports gender-aff...

Do Pediatricians Recommend Vaccines To Make a Profit? T...

A close look at the process by which vaccines are administered shows pediatric p...

RFK, Jr., Tries to Justify Dangerous Health Policies as...

Physicians and medical professionals almost universally agree that Robert F. Ken...

A Reflection on Blood Cancer Awareness Month: Patient S...

At Adaptive, we know our diagnostic tests provide key information that help phys...

Hope restored: The critical role that Minimal Residual ...

Adaptive is dedicated to recognizing patients like Tiffany and to contribute to ...

Among Multiple Myeloma Patients Receiving MRD Testing, ...

MRD testing can help to provide an accurate, ongoing picture of disease and risk...

Clinically Actionable Insights: A Q&A with Dr. Luciano ...

In 2021, Susan Bobulsky sat down with Dr. Luciano Costa to learn about the initi...

Immune Medicine in Action: How Adaptive Immunosequencin...

Adaptive Immunosequencing provided critical insight into the T-cell response eli...

When the Doctor Becomes the Caregiver

In honor of Multiple Myeloma Awareness Month, we sat down with Dr. Hamza Hashmi,...

Decoding Public T-cell Signatures of Disease with Tens ...

In the ever-evolving field of immunology, the study of T-cell responses to vario...

PACE panel urges incentives for exciting new GTT drugs

Luke Rosen had hoped a new treatment would slow the progression of his daughter’...

Ahead of BIO IP Conference, research highlights why bio...

Venture capital funding for life sciences startups plummeted after legal changes...

PACE: Downstream effects of IRA on patients

Three years after the passage of the Inflation Reduction Act (IRA), patient advo...

BIO on the American Road: Indiana, a production powerho...

At a time when the biopharma industry is seeking to increase U.S. manufacturing,...

BIO Coffee Chat: Guiding patients through Part D open e...

Medicare’s 2026 Open Enrollment period for Part D plans began on Oct. 15 and run...